Nuedexta Recommendation by the European Medicines Agency

Nuedexta gets a positive recommendation from the European Medicines Agency for the treatment of Pseudobulbar effect in patients living in Europe. The article can be found here.

Dr. Smith quoted in recent article

Dr. Smith quoted in recent article in the Alzheimer's Research Forum about using stem cell-based screening method to model ALS.

Lancet Neurology - Landmark Paper Published

Lancet Neurology publishes landmark paper of a potential therapy for ALS developed in collaboration with UCSD and Isis Pharmaceutical Co: "An Antisense Oligonucleotide against SOD1 Delivered Intrathecally for Patients with SOD1-Familial Amyotrophic Lateral Sclerosis: a phase 1, randomized, first-in man study."